UR

Umamaheswara Rao Yellela

Active Director Director DIN 11182072
DIN 11182072 First appointment Jul 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Umamaheswara Rao Yellela

Data last updated:

Umamaheswara Rao Yellela is a Director at Myprella Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11182072
Primary Designation Director
Industry Pharma
First Appointment 03 Jul 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Jul 20252025Active

Board colleagues of Umamaheswara Rao Yellela

NameDINCompanyDesignation
Venkat Sunil Yellela08317883Myprella Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Myprella Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Umamaheswara Rao Yellela

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Umamaheswara Rao Yellela

Umamaheswara Rao Yellela currently holds 1 directorship: Myprella Pharmaceuticals Private Limited (Director, since 03 Jul 2025).

Umamaheswara Rao Yellela was first appointed on 03 Jul 2025 as Director at Myprella Pharmaceuticals Private Limited.

The current boards of Umamaheswara Rao Yellela's companies include Venkat Sunil Yellela (Myprella Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available